Peter Norman
Impact in
- Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization
- Physiology top 5%
- Asthma and respiratory diseases
Papers in ⓘ
- Physiology 33
- Asthma and respiratory diseases 31
- Genetics 11
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Phillip J. Gardiner (14 shared papers)Nigel J. Cuthbert (13 shared papers)Trevor S. Abram (11 shared papers)M.G. McKenniff (4 shared papers)Ian W. Rodger (1 shared paper)J.L. Ortiz (2 shared papers)Isabelle Gorenne (2 shared papers)Carlos Labat (2 shared papers)
- Journals
- Expert Opinion on Therapeutic Patents (59 papers)European Journal of Pharmacology (8 papers)Expert Opinion on Investigational Drugs (6 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Prostaglandins (2 papers)
- Partner nations
- United KingdomNorwayUnited States
In The Last Decade
Peter Norman
92 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 87
- Immunology and Allergy 145
- Physiology 582
- Immunology 301
- Genetics 145
- Pharmacology 188
Countries citing papers authored by Peter Norman
This map shows the geographic impact of Peter Norman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Norman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Norman more than expected).
Fields of papers citing papers by Peter Norman
This network shows the impact of papers produced by Peter Norman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Norman. The network helps show where Peter Norman may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Norman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 134 | |
| 2 | 2014 | 129 | |
| 3 | 1994 | 70 | |
| 4 | 1988 | 70 | |
| 5 | 1992 | 67 | |
| 6 | 1991 | 67 | |
| 7 | 2015 | 48 | |
| 8 | 2011 | 45 | |
| 9 | 2010 | 39 | |
| 10 | 2016 | 38 | |
| 11 | 2013 | 33 | |
| 12 | 2012 | 31 | |
| 13 | 1987 | 28 | |
| 14 | 2014 | 26 | |
| 15 | 2011 | 22 | |
| 16 | 2009 | 18 | |
| 17 | 1993 | 18 | |
| 18 | 1990 | 17 | |
| 19 | 1993 | 17 | |
| 20 | 2016 | 17 |
About Peter Norman
Peter Norman is a scholar working on Physiology, Genetics, Pharmacology, Immunology and Pharmacology, having authored 100 papers that have together received 1.3k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (31 papers), Cytokine Signaling Pathways and Interactions (13 papers), Receptor Mechanisms and Signaling (11 papers), Neuropeptides and Animal Physiology (11 papers), Respiratory and Cough-Related Research (10 papers), Mast cells and histamine (9 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Immunology and Allergy (145 citations), Physiology (582 citations), Immunology (301 citations), Genetics (145 citations) and Pharmacology (188 citations). Peter Norman has collaborated with scholars based in United Kingdom, Norway and United States. Frequent co-authors include Phillip J. Gardiner, Nigel J. Cuthbert, Trevor S. Abram, M.G. McKenniff, Ian W. Rodger, J.L. Ortiz, Isabelle Gorenne, Carlos Labat, William A. Massey and L M Lichtenstein. Their work appears in journals such as Expert Opinion on Therapeutic Patents, European Journal of Pharmacology, Expert Opinion on Investigational Drugs, Journal of Pharmacology and Experimental Therapeutics and Prostaglandins.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.